Kuan Arthur 4

What Happened
Arthur Kuan, CEO of CG Oncology (CGON), exercised options on March 4, 2026. He exercised options to purchase 102,871 shares at $1.72 per share (aggregate exercise amount ≈ $176,938) and, per the filing, received 100,000 shares net. The company withheld 2,871 shares to satisfy tax withholding (valued at $61.61/share, ≈ $176,882). The filing notes the reporting person also paid cash to cover the delta of the aggregate exercise price. The company classed the action as an option exercise (code M) with a tax‑withholding disposition (code F); the transaction is not a sale.

Key Details

• Transaction date: 2026-03-04; Form filed: 2026-03-06 (timely).
• Options exercised: 102,871 shares at $1.72/share (total ≈ $176,938).
• Net shares received: 100,000; 2,871 shares withheld for taxes (valued ≈ $176,882).
• Footnotes: F1 confirms a net (cashless) exercise and that the withholding does not represent a sale; F2 states the option was vested and exercisable.
• Shares owned after transaction: not disclosed in this filing.

Context
This was a net/cashless option exercise: options were converted into stock, with a small portion of shares withheld to cover tax obligations and the filer paying cash to satisfy the exercise price/delta. Net exercises are routine corporate actions and do not on their own indicate intent to buy or sell stock in the open market.